Scilex Holding (SCLX) Short term Debt (2021 - 2026)
Scilex Holding (SCLX) recorded quarterly Short term Debt of $80.8 million in Q1 2026, down 2.98% quarter-over-quarter from $83.3 million in Q4 2025, and up 104.81% on a YoY basis from $39.4 million in Q1 2025.
Scilex Holding (SCLX) Short term Debt (2021 - 2026) Analysis & Trends
Scilex Holding's Short term Debt history runs 5 years deep, the most recent figure standing at $80.8 million for Q1 2026.
- In Q1 2026, Short term Debt rose 104.81% year-over-year to $80.8 million; the TTM figure through Mar 2026 stood at $80.8 million (up 104.81% YoY), while the FY2025 annual figure was $83.3 million, up 138.74% from the prior year.
- Short term Debt was $80.8 million for Q1 2026 at Scilex Holding, down from $83.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $115.2 million in Q3 2023 to a low of $15.9 million in Q2 2023.
- Historically, Short term Debt has averaged $68.0 million across 4 years, with a median of $78.1 million in 2024.
- Biggest YoY gain for Short term Debt was 373.55% in 2024; the steepest drop was 67.84% in 2024.
- A 4-year view of Short term Debt shows it stood at $108.4 million in 2023, then tumbled by 67.84% to $34.9 million in 2024, then jumped by 138.74% to $83.3 million in 2025, then retreated by 2.98% to $80.8 million in 2026.
- The last three Short term Debt figures came in at $80.8 million (Q1 2026), $83.3 million (Q4 2025), and $45.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.78 Mn |
| Dec 31, 2025 | 83.26 Mn |
| Sep 30, 2025 | 45.67 Mn |
| Jun 30, 2025 | 39.87 Mn |
| Mar 31, 2025 | 39.44 Mn |
| Dec 31, 2024 | 34.88 Mn |
| Sep 30, 2024 | 84.64 Mn |
| Jun 30, 2024 | 75.37 Mn |
| Mar 31, 2024 | 92.92 Mn |
| Dec 31, 2023 | 108.43 Mn |
| Sep 30, 2023 | 115.22 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Dec 31, 2021 | 37.95 Mn |